doctor holding stethoscope

Acute lymphoblastic leukaemia- ALL (Vijayakrishnan, 2019)

WEEKLY UPDATE: December 12, 2019

STUDY TITLE: Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk

SUMMARY: Discovery of 4 novel genetic variants associated with acute lymphoblastic leukaemia (ALL).

OVERVIEW:  Acute lymphoblastic leukaemia (ALL) is a type of blood cancer that leads to a debilitating overproduction of lymphocytes, a type white blood cells. ALL is the most common cancer for young children, accounting for around 85% of all cases. To identify genetic variants that may contribute to the development of ALL, this genome-wide association study analyzed the genomes of nearly 22,000 individuals of European ancestry. The study discovered 16 ALL-associated genetic variants, of which 4 were novel. The study estimated that the identified loci collectively explain 31% of the variance in genetic risk of ALL.

DID YOU KNOW? Chemotherapy is an effective treatment for ALL. The overall cure rate is ~ 40%. [SOURCE]

SAMPLE RESULTS:

ADDITIONAL RESOURCES:
Acute lymphoblastic leukaemia (ALL)


Share this post
Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on print
Share on email

Get your own kit today!

Contribute to medical breakthroughs and get rewarded. Understand your genes. Own your health data.